BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirschfield GM, Chapman RW, Karlsen TH, Lammert F, Lazaridis KN, Mason AL. The genetics of complex cholestatic disorders. Gastroenterology. 2013;144:1357-1374. [PMID: 23583734 DOI: 10.1053/j.gastro.2013.03.053] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Vasconcellos M, Cozer K, Diniz VS, Baetas-da-Cruz W, Ferreira ML, Silva PC, Schanaider A. Cholecystectomy during ceftriaxone therapy. A translational study with a new rabbit model. Acta Cir Bras 2017;32:995-1005. [PMID: 29319728 DOI: 10.1590/s0102-865020170120000001] [Reference Citation Analysis]
2 Wang Y, Feng D, Wang H, Xu MJ, Park O, Li Y, Gao B. STAT4 knockout mice are more susceptible to concanavalin A-induced T-cell hepatitis. Am J Pathol. 2014;184:1785-1794. [PMID: 24731448 DOI: 10.1016/j.ajpath.2014.02.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
3 Mason AL, Siminovitch KA. New perspectives on the complexity of genetic predisposition to autoimmune liver disease in indigenous Canadians. Liver Int 2018;38:789-91. [DOI: 10.1111/liv.13722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Shabanzadeh DM, Sørensen LT, Jørgensen T. Gallstone disease and mortality: a cohort study. Int J Public Health 2017;62:353-60. [DOI: 10.1007/s00038-016-0916-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
5 Webb GJ, Elsharkawy AM, Hirschfield GM. The etiology of intrahepatic cholestasis of pregnancy: towards solving a monkey puzzle. Am J Gastroenterol. 2014;109:85-88. [PMID: 24402531 DOI: 10.1038/ajg.2013.437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
6 Invernizzi P. Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ. J Autoimmun. 2013;46:1-6. [PMID: 24012346 DOI: 10.1016/j.jaut.2013.08.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
7 Meng Q, Chen XL, Wang CY, Liu Q, Sun HJ, Sun PY, Huo XK, Liu ZH, Yao JH, Liu KX. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis. Toxicol Appl Pharmacol. 2015;283:178-186. [PMID: 25655198 DOI: 10.1016/j.taap.2015.01.020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
8 Oliveira AG, Fiorotto R. Novel approaches to liver disease diagnosis and modeling. Transl Gastroenterol Hepatol 2021;6:19. [PMID: 33824923 DOI: 10.21037/tgh-20-109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang W, Indik S, Wong GK, Mason AL. Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease - authors' reply. Aliment Pharmacol Ther 2015;41:491. [PMID: 25631652 DOI: 10.1111/apt.13082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Karlsen TH, Vesterhus M, Boberg KM. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis. Aliment Pharmacol Ther 2014;39:282-301. [DOI: 10.1111/apt.12581] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 6.2] [Reference Citation Analysis]
11 Yokoda RT, Rodriguez EA. Review: Pathogenesis of cholestatic liver diseases. World J Hepatol 2020; 12(8): 423-435 [PMID: 32952871 DOI: 10.4254/wjh.v12.i8.423] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
12 Poupon R, Corpechot C. Treatment of primary biliary cirrhosis. Expert Opinion on Orphan Drugs 2013;2:11-25. [DOI: 10.1517/21678707.2014.870031] [Reference Citation Analysis]
13 Mason AL. Is PBC a viral infectious disease? Best Pract Res Clin Gastroenterol 2018;34-35:27-39. [PMID: 30343707 DOI: 10.1016/j.bpg.2018.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wang W, Indik S, Wasilenko ST, Faschinger A, Carpenter EJ, Tian Z, Zhang Y, Wong GK, Mason AL. Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease. Aliment Pharmacol Ther. 2015;41:393-405. [PMID: 25521721 DOI: 10.1111/apt.13054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
15 Cipriani S, Renga B, D'Amore C, Simonetti M, De Tursi AA, Carino A, Monti MC, Sepe V, Zampella A, Fiorucci S. Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling. PLoS One 2015;10:e0129866. [PMID: 26177448 DOI: 10.1371/journal.pone.0129866] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
16 Webb GJ, Hirschfield GM. Follicles, germinal centers, and immune mechanisms in primary biliary cirrhosis. Hepatology 2015;61:424-7. [PMID: 25294750 DOI: 10.1002/hep.27552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
17 Verdier J, Luedde T, Sellge G. Biliary Mucosal Barrier and Microbiome. Viszeralmedizin. 2015;31:156-161. [PMID: 26468308 DOI: 10.1159/000431071] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
18 Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging. Physiol Rev 2021;101:683-731. [PMID: 32790577 DOI: 10.1152/physrev.00049.2019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
19 Cheung AC, LaRusso NF, Gores GJ, Lazaridis KN. Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Semin Liver Dis 2017;37:159-74. [PMID: 28564724 DOI: 10.1055/s-0037-1603324] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
20 Eksteen B. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis. Br Med Bull. 2014;110:89-98. [PMID: 24795363 DOI: 10.1093/bmb/ldu008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
21 Li T, Xu L, Zheng R, Wang X, Li L, Ji H, Hu Q. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor. Phytomedicine 2020;68:153153. [PMID: 32018210 DOI: 10.1016/j.phymed.2019.153153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Lytvyak E, Hosamani I, Montano-Loza AJ, Saxinger L, Mason AL. Randomized clinical trial: Combination antiretroviral therapy with tenofovir-emtricitabine and lopinavir-ritonavir in patients with primary biliary cholangitis. Can Liver J 2019;2:31-44. [PMID: 33981960 DOI: 10.3138/canlivj.2018-0020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Acalovschi M. Gallstones in patients with liver cirrhosis: Incidence, etiology, clinical and therapeutical aspects. World J Gastroenterol 2014; 20(23): 7277-7285 [PMID: 24966598 DOI: 10.3748/wjg.v20.i23.7277] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
24 Lytvyak E, Montano-Loza AJ, Mason AL. Combination antiretroviral studies for patients with primary biliary cirrhosis. World J Gastroenterol 2016; 22(1): 349-360 [PMID: 26755881 DOI: 10.3748/wjg.v22.i1.349] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
25 Jacobo-Albavera L, Posadas-Romero C, Vargas-Alarcón G, Romero-Hidalgo S, Posadas-Sánchez R, González-Salazar Mdel C, Carnevale A, Canizales-Quinteros S, Medina-Urrutia A, Antúnez-Argüelles E, Villarreal-Molina T. Dietary fat and carbohydrate modulate the effect of the ATP-binding cassette A1 (ABCA1) R230C variant on metabolic risk parameters in premenopausal women from the Genetics of Atherosclerotic Disease (GEA) Study. Nutr Metab (Lond) 2015;12:45. [PMID: 26579206 DOI: 10.1186/s12986-015-0040-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
26 Mezina A, Karpen SJ. Genetic contributors and modifiers of biliary atresia. Dig Dis 2015;33:408-14. [PMID: 26045276 DOI: 10.1159/000371694] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
27 Sclair SN, Little E, Levy C. Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clin Transl Gastroenterol 2015;6:e109. [PMID: 26312413 DOI: 10.1038/ctg.2015.33] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
28 dos Santos A, Dantas LEC, Traina F, de Albuquerque DM, Chaim EA, Olalla Saad ST. Pyrimidine-5′-nucleotidase Campinas, a new mutation (p.R56G) in the NT5C3 gene associated with pyrimidine-5′-nucleotidase type I deficiency and influence of Gilbert's Syndrome on clinical expression. Blood Cells, Molecules, and Diseases 2014;53:246-52. [DOI: 10.1016/j.bcmd.2014.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Wasilenko ST, Montano-Loza AJ, Mason AL. Is there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis? Viruses. 2013;5:423-438. [PMID: 23348060 DOI: 10.3390/v5020423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
30 Ogese MO, Ahmed S, Alferivic A, Betts CJ, Dickinson A, Faulkner L, French N, Gibson A, Hirschfield GM, Kammüller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell AW, Spraggs CF, Whritenour J, Naisbitt DJ. New Approaches to Investigate Drug-Induced Hypersensitivity. Chem Res Toxicol 2017;30:239-59. [DOI: 10.1021/acs.chemrestox.6b00333] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
31 Degiorgio D, Crosignani A, Colombo C, Bordo D, Zuin M, Vassallo E, Syrén ML, Coviello DA, Battezzati PM. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression. J Gastroenterol 2016;51:271-80. [PMID: 26324191 DOI: 10.1007/s00535-015-1110-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
32 Sharon D, Chen M, Zhang G, Girgis S, Sis B, Graham D, McDougall C, Wasilenko ST, Montano-Loza A, Mason AL. Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease. Liver Int. 2015;35:1442-1450. [PMID: 25302564 DOI: 10.1111/liv.12699] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
33 Caplan L, Kuhn KA. Gastrointestinal and Hepatic Disease in Spondyloarthritis. Rheum Dis Clin North Am 2018;44:153-64. [PMID: 29149924 DOI: 10.1016/j.rdc.2017.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
34 Bell LN, Wulff J, Comerford M, Vuppalanchi R, Chalasani N. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis. Liver Int 2015;35:263-74. [PMID: 25181933 DOI: 10.1111/liv.12680] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
35 Trivedi PJ, Hirschfield GM. The Immunogenetics of Autoimmune Cholestasis. Clin Liver Dis. 2016;20:15-31. [PMID: 26593288 DOI: 10.1016/j.cld.2015.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
36 Karlsen TH, Lammert F, Thompson RJ. Genetics of liver disease: From pathophysiology to clinical practice. Journal of Hepatology 2015;62:S6-S14. [DOI: 10.1016/j.jhep.2015.02.025] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
37 Goubran M, Aderibigbe A, Jacquemin E, Guettier C, Girgis S, Bain V, Mason AL. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation. BMC Med Genet 2020;21:238. [PMID: 33256620 DOI: 10.1186/s12881-020-01173-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Wang M, Liu F, Yao Y, Zhang Q, Lu Z, Zhang R, Liu C, Lin C, Zhu C. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats. J Ethnopharmacol 2021;270:113816. [PMID: 33444723 DOI: 10.1016/j.jep.2021.113816] [Reference Citation Analysis]
39 Montano-Loza AJ, Mason AL. Recurrence of primary biliary cholangitis after liver transplantation: A Japanese perspective. Hepatol Commun 2017;1:391-3. [PMID: 29404467 DOI: 10.1002/hep4.1058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
40 Wang L, Li J, Wang C, Tang R, Liang J, Gong Y, Dai Y, Ding N, Wu J, Dai N, Liu L, Zhao Y, Shao Y, Zhao W, Jiang P, Shi X, Chen W, Tian Y, Liu X, Ma X, Sun Z. Mapping of de novo mutations in primary biliary cholangitis to a disease-specific co-expression network underlying homeostasis and metabolism. J Genet Genomics 2021:S1673-8527(21)00265-4. [PMID: 34433101 DOI: 10.1016/j.jgg.2021.07.019] [Reference Citation Analysis]
41 Juran BD, Lazaridis KN. Environmental factors in primary biliary cirrhosis. Semin Liver Dis. 2014;34:265-272. [PMID: 25057950 DOI: 10.1055/s-0034-1383726] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
42 Goodrich JK, Davenport ER, Beaumont M, Jackson MA, Knight R, Ober C, Spector TD, Bell JT, Clark AG, Ley RE. Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe. 2016;19:731-743. [PMID: 27173935 DOI: 10.1016/j.chom.2016.04.017] [Cited by in Crossref: 502] [Cited by in F6Publishing: 411] [Article Influence: 100.4] [Reference Citation Analysis]
43 Asuri S, Mcintosh S, Taylor V, Rokeby A, Kelly J, Shumansky K, Field LL, Yoshida EM, Arbour L. Primary Biliary Cholangitis in British Columbia First Nations: Clinical features and discovery of novel genetic susceptibility loci. Liver Int 2018;38:940-8. [DOI: 10.1111/liv.13686] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
44 Wang N, Lu Y, Gong J, Xie X, Lin J, Abuduxikuer K, Zhang M, Wang J. Molecular findings in children with inherited intrahepatic cholestasis. Pediatr Res 2020;87:112-7. [DOI: 10.1038/s41390-019-0548-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Su H, Wang Q, Li Y, Jin J, Tan B, Yan D, Zou B, Song G, Weng F, Qiu F. Effect of Different Ratios of Yinchen and Gancao Decoction on ANIT-Treated Cholestatic Liver Injury in Mice and Its Potential Underlying Mechanism. Front Pharmacol 2021;12:611610. [PMID: 33935705 DOI: 10.3389/fphar.2021.611610] [Reference Citation Analysis]
46 Karpen SJ, Kamath BM, Alexander JJ, Ichetovkin I, Rosenthal P, Sokol RJ, Dunn S, Thompson RJ, Heubi JE. Use of a Comprehensive 66-Gene Cholestasis Sequencing Panel in 2171 Cholestatic Infants, Children, and Young Adults. J Pediatr Gastroenterol Nutr 2021;72:654-60. [PMID: 33720099 DOI: 10.1097/MPG.0000000000003094] [Reference Citation Analysis]
47 Tai Y, Xie Y, Tang CW. Compound heterozygous mutations of ABCB11 responsible for benign recurrent intrahepatic cholestasis: Hereditary intrahepatic cholestasis. Journal of Digestive Diseases 2015;16:299-302. [DOI: 10.1111/1751-2980.12227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
48 Yao X, Li Y, Cheng X, Li H. ER stress contributes to alpha-naphthyl isothiocyanate-induced liver injury with cholestasis in mice. Pathol Res Pract 2016;212:560-7. [PMID: 27173049 DOI: 10.1016/j.prp.2016.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
49 Liaskou E, Hirschfield GM, Gershwin ME. Mechanisms of tissue injury in autoimmune liver diseases. Semin Immunopathol. 2014;36:553-568. [PMID: 25082647 DOI: 10.1007/s00281-014-0439-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
50 García-niño WR, Zazueta C. Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection. Pharmacological Research 2015;97:84-103. [DOI: 10.1016/j.phrs.2015.04.008] [Cited by in Crossref: 123] [Cited by in F6Publishing: 95] [Article Influence: 17.6] [Reference Citation Analysis]
51 Voiosu A, Wiese S, Voiosu T, Bendtsen F, Møller S. Bile acids and cardiovascular function in cirrhosis. Liver Int 2017;37:1420-30. [DOI: 10.1111/liv.13394] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
52 Shizuma T. Clinical Characteristics of Concomitant Systemic Lupus Erythematosus and Primary Biliary Cirrhosis: A Literature Review. J Immunol Res 2015;2015:713728. [PMID: 26090497 DOI: 10.1155/2015/713728] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
53 Stieger B, Mahdi ZM. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease. J Pharm Sci 2017;106:2295-301. [PMID: 28385542 DOI: 10.1016/j.xphs.2017.03.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
54 Herbst S, Schirmer S, Posovszky C, Jochum F, Rödl T, Schroeder J, Barth T, Hehr U, Melter M, Vermehren J. Taking the next step forward – Diagnosing inherited infantile cholestatic disorders with next generation sequencing. Molecular and Cellular Probes 2015;29:291-8. [DOI: 10.1016/j.mcp.2015.03.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
55 Yang F, Tang X, Ding L, Zhou Y, Yang Q, Gong J, Wang G, Wang Z, Yang L. Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation. Sci Rep. 2016;6:33052. [PMID: 27624003 DOI: 10.1038/srep33052] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
56 Rebholz C, Krawczyk M, Lammert F. Genetics of gallstone disease. Eur J Clin Invest 2018;48:e12935. [DOI: 10.1111/eci.12935] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
57 Reichert MC, Hall RA, Krawczyk M, Lammert F. Genetic determinants of cholangiopathies: Molecular and systems genetics. Biochim Biophys Acta Mol Basis Dis 2018;1864:1484-90. [PMID: 28757171 DOI: 10.1016/j.bbadis.2017.07.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
58 Montano-Loza AJ, Bhanji RA, Wasilenko S, Mason AL. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment Pharmacol Ther. 2017;45:485-500. [PMID: 27957759 DOI: 10.1111/apt.13894] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
59 Gulamhusein AF, Juran BD, Lazaridis KN. Genome-Wide Association Studies in Primary Biliary Cirrhosis. Semin Liver Dis. 2015;35:392-401. [PMID: 26676814 DOI: 10.1055/s-0035-1567831] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
60 Yu L, Liu X, Yuan Z, Li X, Yang H, Yuan Z, Sun L, Zhang L, Jiang Z. SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model. Front Pharmacol 2017;8:256. [PMID: 28553227 DOI: 10.3389/fphar.2017.00256] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
61 Lammert F, Gurusamy K, Ko CW, Miquel JF, Méndez-Sánchez N, Portincasa P, van Erpecum KJ, van Laarhoven CJ, Wang DQ. Gallstones. Nat Rev Dis Primers 2016;2:16024. [PMID: 27121416 DOI: 10.1038/nrdp.2016.24] [Cited by in Crossref: 160] [Cited by in F6Publishing: 131] [Article Influence: 26.7] [Reference Citation Analysis]
62 Tordai H, Jakab K, Gyimesi G, András K, Brózik A, Sarkadi B, Hegedus T. ABCMdb reloaded: updates on mutations in ATP binding cassette proteins. Database (Oxford) 2017;2017. [PMID: 28365738 DOI: 10.1093/database/bax023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
63 Shagrani M, Burkholder J, Broering D, Abouelhoda M, Faquih T, El-Kalioby M, Subhani SN, Goljan E, Albar R, Monies D, Mazhar N, AlAbdulaziz BS, Abdelrahman KA, Altassan N, Alkuraya FS. Genetic profiling of children with advanced cholestatic liver disease. Clin Genet. 2017;92:52-61. [PMID: 28039895 DOI: 10.1111/cge.12959] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
64 Zhang Y, Guo T, Yang F, Mao Y, Li L, Liu C, Sun Q, Li Y, Huang J. Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males. Hepatol Int 2018;12:429-37. [PMID: 30132178 DOI: 10.1007/s12072-018-9889-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
65 Kouroumalis E, Notas G. Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther 2015; 6(3): 32-58 [PMID: 26261733 DOI: 10.4292/wjgpt.v6.i3.32] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
66 Ross KA. Coherent somatic mutation in autoimmune disease. PLoS One 2014;9:e101093. [PMID: 24988487 DOI: 10.1371/journal.pone.0101093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
67 Sharon D, Mason AL. Role of novel retroviruses in chronic liver disease: assessing the link of human betaretrovirus with primary biliary cirrhosis. Curr Infect Dis Rep. 2015;17:460. [PMID: 25754451 DOI: 10.1007/s11908-014-0460-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
68 Tanaka H, Imasato M, Yamazaki Y, Matsumoto K, Kunimoto K, Delpierre J, Meyer K, Zerial M, Kitamura N, Watanabe M, Tamura A, Tsukita S. Claudin-3 regulates bile canalicular paracellular barrier and cholesterol gallstone core formation in mice. Journal of Hepatology 2018;69:1308-16. [DOI: 10.1016/j.jhep.2018.08.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
69 Li S, Wang R, Wu B, Wang Y, Song F, Gu Y, Yuan Y. Salvianolic acid B protects against ANIT-induced cholestatic liver injury through regulating bile acid transporters and enzymes, and NF-κB/IκB and MAPK pathways. Naunyn Schmiedebergs Arch Pharmacol 2019;392:1169-80. [PMID: 31098695 DOI: 10.1007/s00210-019-01657-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
70 Pieters A, Gijbels E, Cogliati B, Annaert P, Devisscher L, Vinken M. Biomarkers of cholestasis. Biomark Med 2021;15:437-54. [PMID: 33709780 DOI: 10.2217/bmm-2020-0691] [Reference Citation Analysis]
71 van Golen RF, Olthof PB, de Haan LR, Coelen RJ, Pechlivanis A, de Keijzer MJ, Weijer R, de Waart DR, van Kuilenburg ABP, Roelofsen J, Gilijamse PW, Maas MA, Lewis MR, Nicholson JK, Verheij J, Heger M. The pathophysiology of human obstructive cholestasis is mimicked in cholestatic Gold Syrian hamsters. Biochim Biophys Acta Mol Basis Dis 2018;1864:942-51. [PMID: 29196240 DOI: 10.1016/j.bbadis.2017.11.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Lammert F, Hochrath K. A letter on ABCB4 from Iceland: On the highway to liver disease. Clinics and Research in Hepatology and Gastroenterology 2015;39:655-8. [DOI: 10.1016/j.clinre.2015.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
73 Perricone C, Versini M, Ben-ami D, Gertel S, Watad A, Segel MJ, Ceccarelli F, Conti F, Cantarini L, Bogdanos DP, Antonelli A, Amital H, Valesini G, Shoenfeld Y. Smoke and autoimmunity: The fire behind the disease. Autoimmunity Reviews 2016;15:354-74. [DOI: 10.1016/j.autrev.2016.01.001] [Cited by in Crossref: 97] [Cited by in F6Publishing: 83] [Article Influence: 16.2] [Reference Citation Analysis]
74 Villanacci V, Del Sordo R, Salemme M, Cadei M, Sidoni A, Bassotti G. The enteric nervous system in patients with calculous and acalculous gallbladder. Dig Liver Dis 2016;48:792-5. [PMID: 27068404 DOI: 10.1016/j.dld.2016.03.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Wang L, Sun X, Qiu J, Cai Y, Ma L, Zhao P, Jiang Y. Increased numbers of circulating ICOS⁺ follicular helper T and CD38⁺ plasma cells in patients with newly diagnosed primary biliary cirrhosis. Dig Dis Sci 2015;60:405-13. [PMID: 25404409 DOI: 10.1007/s10620-014-3372-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
76 Karpen HE, Karpen SJ. Bile Acid Metabolism During Development. Fetal and Neonatal Physiology. Elsevier; 2017. pp. 913-929.e4. [DOI: 10.1016/b978-0-323-35214-7.00095-0] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
77 Hirschfield GM, Siminovitch KA. Genetics in PBC: What Do the “Risk Genes” Teach Us? Clinic Rev Allerg Immunol 2015;48:176-81. [DOI: 10.1007/s12016-014-8419-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
78 Telbisz Á, Homolya L. Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function. Expert Opin Ther Targets 2016;20:501-14. [PMID: 26573700 DOI: 10.1517/14728222.2016.1102889] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
79 Chapman RW. Update on primary sclerosing cholangitis. Clin Liver Dis (Hoboken). 2017;9:107-110. [PMID: 30992971 DOI: 10.1002/cld.633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
80 Dietrich CG, Geier A. Effect of drug transporter pharmacogenetics on cholestasis. Expert Opin Drug Metab Toxicol. 2014;10:1533-1551. [PMID: 25260651 DOI: 10.1517/17425255.2014.963553] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
81 Wang NL, Li LT, Wu BB, Gong JY, Abuduxikuer K, Li G, Wang JS. The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency. PLoS One 2016;11:e0153114. [PMID: 27050426 DOI: 10.1371/journal.pone.0153114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
82 Chen H, Huang X, Min J, Li W, Zhang R, Zhao W, Liu C, Yi L, Mi S, Wang N, Wang Q, Zhu C. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2. Journal of Ethnopharmacology 2016;179:197-207. [DOI: 10.1016/j.jep.2015.12.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
83 Hua W, Zhang S, Lu Q, Sun Y, Tan S, Chen F, Tang L. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice. J Ethnopharmacol 2021;266:113432. [PMID: 33011367 DOI: 10.1016/j.jep.2020.113432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
84 Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914-928. [PMID: 24389305 DOI: 10.1053/j.gastro.2013.12.032] [Cited by in Crossref: 147] [Cited by in F6Publishing: 131] [Article Influence: 16.3] [Reference Citation Analysis]
85 Min J, Chen H, Gong Z, Liu X, Wu T, Li W, Fang J, Huang T, Zhang Y, Zhao W, Zhu C, Wang Q, Mi S, Wang N. Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury. Molecules 2018;23:E2287. [PMID: 30205454 DOI: 10.3390/molecules23092287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
86 Yang QL, Yang F, Gong JT, Tang XW, Wang GY, Wang ZT, Yang L. Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses. Acta Pharmacol Sin 2016;37:1218-28. [PMID: 27498779 DOI: 10.1038/aps.2016.86] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
87 Kunst RF, Niemeijer M, van der Laan LJW, Spee B, van de Graaf SFJ. From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease. Biochem Pharmacol 2020;180:114173. [PMID: 32717228 DOI: 10.1016/j.bcp.2020.114173] [Reference Citation Analysis]
88 Zen Y, Hübscher SG, Nakanuma Y. Bile Duct Diseases. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 515-93. [DOI: 10.1016/b978-0-7020-6697-9.00009-1] [Cited by in Crossref: 9] [Article Influence: 2.3] [Reference Citation Analysis]
89 Stickel F, Moreno C, Hampe J, Morgan MY. The genetics of alcohol dependence and alcohol-related liver disease. J Hepatol 2017;66:195-211. [PMID: 27575312 DOI: 10.1016/j.jhep.2016.08.011] [Cited by in Crossref: 78] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
90 Zhang G, Bashiri K, Kneteman M, Cave K, Hong Y, Mackey JR, Alter HJ, Mason AL. Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease. J Oncol 2020;2020:8958192. [PMID: 32411244 DOI: 10.1155/2020/8958192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]